Drug delivery in cochlear implantation

References

• von Ilberg C, Kiefer J, Tillein J, et al. Electric-acoustic stimulation of the auditory system. New technology for severe hearing loss. ORL J Otorhinolaryngol Relat Spec. 1999;61(6):334–340.
   PubMed Web of Science ®Google Scholar
• Park LR, Teagle HFB, Gagnon E, et al. Electric-acoustic stimulation outcomes in children. Ear Hear. 2019;40(4):849–857.
   PubMed Web of Science ®Google Scholar
• Helbig S, Van de Heyning P, Kiefer J, et al. Combined electric acoustic stimulation with the PULSARCI(100) implant system using the FLEX(EAS) electrode array. Acta Otolaryngol. 2011;131(6):585–595.
   PubMed Web of Science ®Google Scholar
• Chole RA. Endoscopic view of the scala tympani. Otol Neurotol. 2015;36(3):e97–e98.
   PubMed Web of Science ®Google Scholar
• Lin HC, Ren Y, Lysaght AC, et al. Proteome of normal human perilymph and perilymph from people with disabling vertigo. PLoS One. 2019;14(6):e0218292.
   PubMed Web of Science ®Google Scholar
• Hanekom T. Modelling encapsulation tissue around cochlear implant electrodes. Med Biol Eng Comput. 2005;43(1):47–55.
   PubMed Web of Science ®Google Scholar
• Karamert R, et al. Assessment of cochlear implant revision surgeries in a cohort of 802 patients. Otol Neurotol. 2019;40(4):464–470.
   PubMed Web of Science ®Google Scholar
• Ryu KA, Lyu A-R, Park H, et al. Intracochlear bleeding enhances cochlear fibrosis and ossification: an animal study. PLoS One. 2015;10(8):e0136617.
   PubMed Web of Science ®Google Scholar
• Gstoettner W, Kiefer J, Baumgartner W-D, et al. Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol. 2004;124(4):348–352.
   PubMed Web of Science ®Google Scholar
• Herrlich S, Spieth S, Gerstmann H, et al. Drug release mechanisms of steroid eluting rings in cardiac pacemaker lead electrodes. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:681–684.
   Google Scholar
• Sakata E, Kitago Y, Murata Y, et al. Treatment of Meniere’s disease: middle ear infusion with lidocaine and steroid solution. Auris Nasus Larynx. 1986;13(2):79–89.
   PubMedGoogle Scholar
• Available from: https://cordis.europa.eu/project/id/QLG3-CT-2002-01563.
   Google Scholar
• Available from: https://cordis.europa.eu/project/id/26556.
   Google Scholar
• Available from: https://cordis.europa.eu/project/id/281056.
   Google Scholar
• Braun S, Ye Q, Radeloff A, et al. Protection of inner ear function after cochlear implantation: compound action potential measurements after local application of glucocorticoids in the guinea pig cochlea. ORL J Otorhinolaryngol Relat Spec. 2011;73(4):219–228.
   PubMed Web of Science ®Google Scholar
• Giordano P, Hatzopoulos S, Giarbini N, et al. A soft-surgery approach to minimize hearing damage caused by the insertion of a cochlear implant electrode: a guinea pig animal model. Otol Neurotol. 2014;35(8):1440–1445.
   PubMed Web of Science ®Google Scholar
• Ye Q, Tillein J, Hartmann R, et al. Application of a corticosteroid (triamcinolon) protects inner ear function after surgical intervention. Ear Hear. 2007;28(3):361–369.
   PubMed Web of Science ®Google Scholar
• Honeder C, Zhu C, Gausterer JC, et al. Sustained-release triamcinolone acetonide hydrogels reduce hearing threshold shifts in a model for cochlear implantation with hearing preservation. Audiol Neurootol. 2019;24(5):237–244.
   PubMed Web of Science ®Google Scholar
• Souza M, Costa KVTD, Vitorino PA, et al. Effect of antioxidant supplementation on the auditory threshold in sensorineural hearing loss: a meta-analysis. Braz J Otorhinolaryngol. 2018;84(3):368–380.
   PubMed Web of Science ®Google Scholar
• Eshraghi AA, Roell J, Shaikh N, et al. A novel combination of drug therapy to protect residual hearing post cochlear implant surgery. Acta Otolaryngol. 2016;136(4):420–424.
   PubMed Web of Science ®Google Scholar
• Scheper V, Schmidtheisler M, Lasch F, et al. T. Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients. Trials. 2020;21(1):643.
   PubMed Web of Science ®Google Scholar
• Vivero RJ, Joseph DE, Angeli S, et al. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope. 2008;118(11):2028–2035.
   PubMed Web of Science ®Google Scholar
• Ahmadi N, Gausterer JC, Honeder C, et al. Long-term effects and potential limits of intratympanic dexamethasone-loaded hydrogels combined with dexamethasone-eluting cochlear electrodes in a low-insertion trauma Guinea pig model. Hear Res. 2019;384:107825.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jolly C, Braun S, et al. Effects of a dexamethasone-releasing implant on cochleae: a functional, morphological and pharmacokinetic study. Hear Res. 2015;327:89–101.
   PubMed Web of Science ®Google Scholar
• Niedermeier K, Braun S, Fauser C, et al. A safety evaluation of dexamethasone-releasing cochlear implants: comparative study on the risk of otogenic meningitis after implantation. Acta Otolaryngol. 2012;132(12):1252–1260.
   PubMed Web of Science ®Google Scholar
• Niedermeier K, Braun S, Fauser C, et al. Pneumococcal meningitis post cochlear implantation: development of an animal model in the guinea pig. Hear Res. 2012;289(1–2):108–115.
   PubMed Web of Science ®Google Scholar
• Ghavi FF, Mirzadeh H, Imani M, et al. Corticosteroid-releasing cochlear implant: a novel hybrid of biomaterial and drug delivery system. J Biomed Mater Res B Appl Biomaterial. 2010;94(2):388–398.
   PubMed Web of Science ®Google Scholar
• Farhadi M, Jalessi M, Salehian P, et al. Dexamethasone eluting cochlear implant: histological study in animal model. Cochlear Implants Int. 2013;14(1):45–50.
   PubMedGoogle Scholar
• Bas E, Bohorquez J, Goncalves S, et al. Electrode array-eluted dexamethasone protects against electrode insertion trauma induced hearing and hair cell losses, damage to neural elements, increases in impedance and fibrosis: a dose response study. Hear Res. 2016;337:12–24.
   PubMed Web of Science ®Google Scholar
• Wilk M, Hessler R, Mugridge K, et al. Impedance changes and fibrous tissue growth after cochlear implantation are correlated and can be reduced using a dexamethasone eluting electrode. PLoS One. 2016;11(2):e0147552.
   PubMed Web of Science ®Google Scholar
• Zulueta-Santos C, Manrique-Huarte R, Calavia D, et al. Cochlear implantation with a dexamethasone eluting electrode array: functional and anatomical changes in non-human primates. Otol Neurotol. 2020;41(7):e812–e822.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jolly C, Braun S, et al. In vitro and in vivo pharmacokinetic study of a dexamethasone-releasing silicone for cochlear implants. Eur Arch Otorhinolaryngol. 2016;273(7):1745–1753.
   PubMed Web of Science ®Google Scholar
• Liebau A, Schilp S, Mugridge K, et al. Long-term in vivo release profile of dexamethasone-loaded silicone rods implanted into the cochlea of guinea pigs. Front Neurol. 2019;10:1377.
   PubMed Web of Science ®Google Scholar
• Greenwood D. A cochlear frequency-position function for several species-29 years later. J Acoust Soc Am. 1990;87(6):2592–2605.
   PubMed Web of Science ®Google Scholar
• Ibrahim HN, Helbig S, Bossard D, et al. Surgical trauma after sequential insertion of intracochlear catheters and electrode arrays (a histologic study). Otol Neurotol. 2011;32(9):1448–1454.
   PubMed Web of Science ®Google Scholar
• Prentzler NK, Salcher R, Lenarz T, et al. Dose-dependent transient decrease of impedances by deep intracochlear injection of Triamcinolone with a cochlear catheter prior to cochlear implantation- 1-year data. Front Neurol. 2020;11:258.
   PubMed Web of Science ®Google Scholar